Personality and HIV disease progression: Role of NEO-PI-R openness, extraversion, and profiles of engagement

Psychosomatic Medicine

Volumn 70, Issue 2, 2008, Pages 245-253

  Ironson, Gail H ^a,c   O'Cleirigh, Conall ^a,d   Weiss, Alexander ^b,e   Schneiderman, Neil ^a   Costa, Paul T ^b  

^a UNIVERSITY OF MIAMI   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c Department of Biology   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Conscientiousness.; Disease progression; Five Factor Model; HIV AIDS; Openness; Personality

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; EFAVIRENZ; PROTEINASE INHIBITOR; TENOFOVIR DISOPROXIL;

ADULT; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DISEASE COURSE; EXTRAVERSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NEUROSIS; PERSONALITY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RISK ASSESSMENT; STRESS; STRUCTURED QUESTIONNAIRE; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MODELS, PSYCHOLOGICAL; PATIENT COMPLIANCE; PERSONALITY; UNITED STATES; VIRAL LOAD;

EID: 39149140994     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31816422fc     Document Type: Article

References (44)

1. Bogg T, Roberts B. Conscientiousness and health-related behaviors: a meta-analysis of the leading behavioral contributors to mortality. Psychol Bull 2004;130:887-919.
2. Pervin LA, John OP. Personality: Theory and Research. Oxford, England: John Wiley & Sons; 1997.
3. Costa PT Jr, McCrae RR. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) Professional Manual. Odessa, FL: Psychological Assessment Resources, Inc; 1992.
4. Christensen AJ, Ehlers SL, Wiebe JS, Moran PJ, Raichle K, Ferneyhough K, Lawton WJ. Patient personality and mortality: a 4-year prospective examination of chronic renal insufficiency. Health Psychol 2002;21:315-20.
5. Brickman AL, Yount SE, Blaney NT, Rothberg ST, Kaplan DA. Personality traits and long-term health status: the influence of neuroticism and conscientiousness on renal deterioration in type-1 diabetes. Psychosomatics 1996;37:459-68.
6. Boyle SH, Mark DB, Siegler IC, Williams RB, Barefoot JC. Conscientiousness as a predictor of survival in coronary patients. Annual meeting of the American Psychosomatic Society. Phoenix, AZ, 2003.
7. O'Cleirigh C, Ironson G, Weiss A, Costa PT Jr. Conscientiousness predicts disease progression (CD4 and VL) in people living with HIV. Health Psychology 2007;26(4):473-80.
8. Weiss A, Costa PT Jr. Domain and facet personality predictors of all-cause mortality among Medicare patients aged 65 to 100. Psychosom Med 2005;67:724-33.
9. Wilson RS, Mendes de Leon CF, Bienias JL, Evans DA, Bennett DA. Personality and mortality in old age. J Gerontology B Psychol Sci Soc Sci 2004;59:110-6.
10. Friedman HS, Tucker JS, Schwartz JE, Martin LR, Tomlinson-Keasey C, Wingard DL, Criqui MH. Childhood conscientiousness and longevity: health behaviors and death. J Pers Soc Psychol 1995;68:696-703.
11. McCann SJH. Longevity, big five personality factors, and health behaviors: presidents from Washington to Nixon. J Psychol 2005;139:273-86.
12. Wilson RS, Krueger KR, Gu L, Bienias JL, Mendes de Leon CF, Evans DA. Neuroticism, extraversion, and mortality in a defined population of older persons. Psychosom Med 2005;67:841-5.
13. Eysenck HJ. Prediction of cancer and coronary heart disease mortality by means of a personality inventory: results of a 15-year follow-up study. Psychol Rep 1993;72:499-516.
14. Carinci F, Nicolucci A, Ciampi A, Labbrozzi D, Bettinardi O, Zotti AM, Tognoni G. Role of interactions between psychological and clinical factors in determining 6-month mortality among patients with acute myocardial infarction. Application of recursive partitioning techniques to the GISSI-2 database. Gruppo Italiano per lo Studio della Sopravvivenze nell' Infarto Miocardico. Eur Heart J 1997;18:835-45.
15. Korten AE, Jorm AF, Jiao Z, Letenneur L, Jacomb PA, Henderson AS, Christensen H, Rogers B. Health, cognitive, and psychosocial factors as predictors of mortality in an elderly community sample. J Epidemiol Community Health 1999;53:83-8.
16. Almada SJ, Zonderman AB, Shekelle RB, Dyer AR, Daviglus ML, Costa PT Jr, Stamler J. Neuroticism and cynicism and risk of death in middle-aged men: the western electric study. Psychosom Med 1991;53:165-75.
17. Shapiro SL, Lopez AM, Schwartz GE, Bootzin R, Figueredo AJ, Braden CJ, Kurker SF. Quality of life and breast cancer: relationship to psychosocial variables. J Clin Psychol 2001;57:501-19.
18. Nakaya N, Tsubono Y, Nishino Y, Hosokawa T, Fukudo S, Shibuya D, Akizuki N, Yoshikawa E, Kobayakawa M, Fujimori M, Saito-Nakaya K, Uchitomi Y, Tsuji I. Personality and cancer survival: the Miyagi cohort study. Br J Cancer 2005;92:2089-94.
19. Hansen PE, Floderus B, Frederiksen K, Johansen C. Personality traits, health behavior, and risk for cancer: a prospective study of Swedish twin court. Cancer 2005;103:1082-91.
20. Morris PL, Robinson RG, Samuels J. Depression, introversion and mortality following stroke. Aust N Z J Psychiatry 1993;27:443-9.
21. Temoshok L. Personality, coping style, emotion and cancer: towards an integrative model. Cancer Surv 1987;6:545-67.
22. Denollet J, Sys SU, Stroobant N, Rombouts H, Gillebert TC, Brutsaert DL. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996;347:417-21.
23. Barefoot JC, Dahlstrom WG, Williams RB Jr. Hostility, CHD incidence and total mortality: a 25-year follow-up study of 255 physicians. Psychosom Med 1983;45:59-63.
24. Shekelle RB, Gale M, Ostfeld AM, Paul O. Hostility, risk of coronary disease and mortality. Psychosom Med 1983;45:109-14.
25. Ironson G, O'Cleirigh C, Fletcher MA, Laurenceau JP, Balbin E, Klimas N, Schneiderman N, Solomon G. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med 2005;67:1013-21.
26. Ironson G, Friedman A, Klimas N, Antoni M, Fletcher M, LaPerriere A, Simoneau J, Schneiderman N. Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. Int J Behav Med 1994;1:90-105.
27. Ironson G, Balbin E, Stuetzle R, Fletcher MA, O'Cleirigh C, Laurenceau JP, Schneiderman N, Solomon G. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depression. Int J Behav Med 2005;12:86-97.
28. Terracciano AT, Costa PT. Smoking and the five-factor model of personality. Addiction 2004;99:472-81.
29. McCrae RR, Costa PT Jr, Martin TA, Oryol VE, Senin IG, O'Cleirigh C. Personality correlates of HIV stigmatization in Russia and the United States. J Res Pers 2007;41(1):190-6.
30. Ironson G, Solomon G, Cruess D, Barroso J, Stivers M. Psychosocial factors related to long-term survival with HIV/AIDS. Clin Psychol Psychother 1995;2:249-66.
31. Leserman J, Whetten K, Lowe K, Stangl D, Swartz MS, Thielman NM. How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south 2005. Psychosom Med 67:500-7.
32. Power C, Selnes O, Grim J, McArthur J. HIV dementia scale: a rapid screening test. J AIDS 1995;8:271-8.
33. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R (SCID). New York: New York State Psychiatric Institute, Biometrics Research; 1987.
34. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-66.
35. DHHS/Henry J. Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at http://aidsinfo.nih.gov/. Accessed 25 January, 2007.
36. Raudenbush SW, Bryk AS, Cheong YF, Congdon RC. HLM5: Hierarchical Linear and Nonlinear Modeling. Lincolnwood, IL: Scientific Software International; 2002.
37. Bryk AS, Raudenbush SW. Hierarchical Linear Models: Applications and Data Analysis Methods. 2nd ed. Thousand Oaks, CA: Sage; 2002.
38. Wiggins JS, Trapnell PD. Personality structure: the return of the big five. In: Brigs SR, Hogan R, Jones WH, editors. Handbook of Personality Psychology. New York: Academic Press; 1992.
39. Trobst KK, Wiggins JS, Costa PT Jr, Herbst JH, McCrae RR, Masters HL III. Personality psychology and problem behaviors: HIV risk and the five-factor model. J Pers 2000;68:1233-52.
40. Leserman J, Petitto JM, Gu H, Gaynes BN, Barroso J, Golden RN, Perkins DO, Folds JD, Evans DL. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med 2002;32:1059-73.
41. Moskowitz JT. Positive affect predicts lower risk of AIDS mortality. Psychosom Med 2003;65:620-6.
42. Cole SW, Kemeny ME, Taylor SE, Visscher BR, Fahey JL. Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity. Psychosom Med 1996;58:232-3.
43. O'Cleirigh C, Ironson G, Antoni M, Fletcher MA, McGuffey L, Balbin E, Shneiderman N, Solomon G. Emotional expression and depth processing of trauma and their relation to long-term survival in patients with HIV/AIDS. J Psychosom Res 2003;54(3):225-35.
44. Safren S, Hendriksen E, Mayer K, Pickard R, Otto M. Cognitive behavioral therapy for HIV medication adherence and depression. Cognitive Behavior and Practice 2004;11:415-24.